Peptides - Metabolic
Survodutide
Dual GLP-1/glucagon agonist for significant weight loss and metabolic improvement
Dosage
0.5-4.8mg weekly
Results
8-12 weeks
Frequency
Weekly
Cost
$250-450/month
Estimated monthly
$250-450
Administration
Method
Subcutaneous injection
Timing
AM
Food
Any time
Key Benefits
- Substantial weight loss
- Dual receptor activity
- Improved liver health
- Enhanced metabolic rate
- Cardiovascular benefits
Stacks Well With
Important Considerations
- • MEN2
- • Thyroid cancer history
- • Pancreatitis
- • Pregnancy
Additional Notes
- • Newer GLP-1 competitor
- • Strong liver fat reduction
- • Titrate slowly
Research & Studies
Survodutide: Dual GLP-1/Glucagon Agonist Phase 2
2023·Clinical Trial
Survodutide: NAFLD Liver Fat Reduction Trial
2024·Clinical Trial
Research provided for educational purposes. Always consult a healthcare provider.